.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Antiplatelet therapy remains a cornerstone for preventing cardiovascular and cerebrovascular events. However, clinicians often face life-threatening bleeding risks that necessitate the urgent restoration of platelet activity. Recent research has identified a novel metabolic pathway involving desmopressin for antiplatelet reversal, offering a clearer understanding of how this synthetic analogue of vasopressin restores hemostasis. Specifically, a new study demonstrates that desmopressin acetate mitigates platelet dysfunction by modulating redox states through a glycolysis-dependent mechanism.
While clinicians previously attributed the hemostatic effects of desmopressin primarily to the release of von Willebrand factor and Factor VIII, this study uncovers a deeper cellular mechanism. Researchers employed mouse models and analyzed patient plasma to trace the molecular pathways involved. They found that desmopressin effectively restores coagulation by enhancing platelet glycolysis. This metabolic shift occurs through the activation of the phosphofructokinase-2/fructose-2,6-bisphosphatase 3 (PFKFB3) enzyme. Consequently, the increased glycolytic flux drives the generation of intracellular reactive oxygen species (ROS).
Furthermore, the study highlighted the role of peroxiredoxin-5 (PRDX5), an antioxidant enzyme. Antiplatelet therapy typically leads to the upregulation of PRDX5, which suppresses platelet activity. Desmopressin administration reverses this effect by downregulating PRDX5 expression. This downregulation, driven by glycolysis-induced ROS, is essential for restoring platelet responsiveness and improving coagulation capacity during severe hemorrhage.
The findings provide a robust mechanistic framework for using desmopressin in emergency settings. Validation in patients receiving dual antiplatelet therapy for unruptured intracranial aneurysms confirms the translational potential of these results. Therefore, redox modulation represents a critical therapeutic target for managing antiplatelet-related bleeding. Moreover, the study suggests that pharmacological inhibition of PRDX5 could serve as an alternative strategy to enhance platelet function. These insights help refine clinical protocols for surgical and neurocritical care patients where even minor hematoma expansion can be fatal.
Desmopressin enhances platelet function by stimulating the release of clotting factors and activating a glycolysis-driven reactive oxygen species (ROS) pathway that restores platelet aggregation and adhesion.
PRDX5 acts as an antioxidant enzyme that is upregulated during antiplatelet therapy, leading to suppressed platelet activity. Desmopressin helps by lowering PRDX5 levels through ROS generation.
Research suggests it is particularly useful for reversing the effects of aspirin and P2Y12 inhibitors like clopidogrel by bypassing standard inhibitory pathways and activating metabolic triggers for platelet rescue.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and is not a substitute for professional clinical judgment. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wang K et al. Glycolysis-dependent reactive oxygen species mediate desmopressin acetate-induced rescue of platelet dysfunction caused by antiplatelet therapy. Med Gas Res. 2026 Mar 26. doi: 10.4103/mgr.MEDGASRES-D-25-00353. PMID: 41888039.
Shahzad F, et al. Desmopressin for Antiplatelet Reversal in Intracerebral Hemorrhage in Adults. ACEP Now. 2024.
Hvas AM, et al. Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review. Neurocrit Care. 2020;33(1):274-286. doi: 10.1007/s12028-020-01055-6.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research highlights a glycolysis-ROS-PRDX5 pathway as the key mechanism for desmopressin acetate in reversing antiplatelet-induced platelet dysfunction....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
